Austin-based Genprex, Inc., a clinical-stage gene therapy company specializing in cancer and diabetes treatments, is making strides with its lead product candidate REQORSA (GPX-001). REQORSA has shown great promise in treating non-small cell lung cancer and small cell lung cancer. In addition, the company is in the process of developing GPX-002, a gene therapy still in a preclinical stage, as a potential treatment for diabetes. Founded in 2009, Genprex, Inc. has continued to prioritize innovation and cutting-edge research in its mission to improve treatment outcomes for cancer and diabetes patients.
Genprex, Inc.'s ticker is GNPX
The company's shares trade on the NASDAQ stock exchange
They are based in Austin, Texas
There are 1-10 employees working at Genprex, Inc.
It is https://www.genprex.com/
Genprex, Inc. is in the Healthcare sector
Genprex, Inc. is in the Biotechnology industry
The following five companies are Genprex, Inc.'s industry peers: